Skip to main content
RPAY
NASDAQ Trade & Services

Activist Investor Veradace Capital Declares 8.6% Stake, Demands Board Changes at Repay Holdings

Analysis by Wiseek.aiReviewed by Editorial Team
Sentiment info
Negative
Importance info
9
Price
$3.16
Mkt Cap
$275.486M
52W Low
$2.3
52W High
$6.055
Market data snapshot near publication time

summarizeSummary

Activist investor Veradace Capital Management has filed a Schedule 13D, formally declaring an 8.6% stake in Repay Holdings Corp and demanding board changes and expressing concerns over the KUBRA acquisition.


check_boxKey Events

  • Activist Stake Declared

    Veradace Capital Management LLC and its affiliates formally disclosed an 8.6% beneficial ownership stake in Repay Holdings Corp, representing a significant portion of the company's market capitalization.

  • Demands for Board Changes

    The activist investor is seeking the addition of two shareholder-supported directors to the Board of Directors to bring fresh perspectives on investor credibility, capital allocation, and value maximization.

  • Opposition to KUBRA Acquisition

    Veradace expressed concerns regarding the Issuer's performance over recent years and noted shareholder opposition to the KUBRA Data Transfer LTD acquisition.

  • Significant Investment

    The aggregate purchase price for the reported securities was approximately $31.3 million, indicating a substantial commitment by the activist investor.


auto_awesomeAnalysis

Veradace Capital Management LLC and its affiliates have formally declared an 8.6% activist stake in Repay Holdings Corp through this Schedule 13D filing. This marks a significant shift from a previously passive investment (13G filing) to an active intent to influence company strategy. The filing explicitly states Veradace's concerns regarding the Issuer's performance, shareholder opposition to the KUBRA acquisition, and the absence of shareholder perspective on the board. The activist group is demanding the addition of two shareholder-supported directors. This formal declaration, following recent news reports and the company's adoption of a poison pill, signals an escalating conflict between management and a major shareholder, potentially leading to a proxy fight or significant corporate changes. The aggregate investment of approximately $31.3 million underscores the seriousness of Veradace's campaign.

At the time of this filing, RPAY was trading at $3.16 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $275.5M. The 52-week trading range was $2.30 to $6.06. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed RPAY - Latest Insights

RPAY
Apr 27, 2026, 11:42 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
RPAY
Apr 27, 2026, 8:05 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
RPAY
Apr 27, 2026, 8:03 AM EDT
Filing Type: 8-K
Importance Score:
7
RPAY
Apr 17, 2026, 4:47 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
RPAY
Apr 17, 2026, 1:53 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
RPAY
Apr 15, 2026, 6:25 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
RPAY
Apr 14, 2026, 8:40 AM EDT
Filing Type: 8-K
Importance Score:
8
RPAY
Apr 13, 2026, 5:06 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
RPAY
Apr 13, 2026, 8:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
RPAY
Apr 10, 2026, 4:01 PM EDT
Filing Type: 4/A
Importance Score:
7